• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Menomune-A/C/Y/W-135

STN: BL 103926       
Proper Name: Meningococcal Polysaccharide Vaccine, Groups A, C, Y, W135 Combined
Tradename: Menomune-A/C/Y/W-135
Manufacturer: Sanofi Pasteur Inc, License #1725
Indication:  

  • For active immunization against invasive meningococcal disease caused by Neisseria meningiditis serogroups A, C, Y, and W-135. Menomune – A/C/Y/W-135 vaccine is approved for use in persons 2 years of age and older.

 

 

-

Supporting Documents

-
 

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002